NCT02043522 - 123I-mIBG SPECT Imaging | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Heart FailureCoronary Artery Disease

Interventions

DRUG

Radioisotope

One dose of 10 mCi (370 mBq:± 10%, calibrated to time of injection) of 123I-mIBG (AdreView) administered as a single intravenous bolus over 1 or 2 minutes, followed by a saline flush.

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa